Asthma Management in the Era of the COVID-19 Pandemic

Simple item page
dc.contributor.authorKlouda, Timothyen_US
dc.contributor.authorPillarisetti, Advaiten_US
dc.contributor.authorXie, Annayen_US
dc.contributor.authorKabra, Sushilen_US
dc.contributor.authorSaradhi, Naveenen_US
dc.contributor.authorKatwa, Umakanthen_US
dc.date.accessioned2023-08-19T04:53:38Z
dc.date.available2023-08-19T04:53:38Z
dc.date.issued2022-02
dc.description.abstractAsthma is common in children and exacerbations are usually triggered by respiratory viruses. There was considerable concern about the impact of COVID-19 on children with asthma. It was expected that children with asthma would fare poorly during the pandemic. However, the reported efect of the COVID-19 pandemic on pediatric asthma including acute asthma admissions, does not appear to be signifcant, but this needs careful follow-up. The socioeconomic efects of the pandemic and reduced healthcare access could potentially impact on ongoing delivery of health care in chronic respiratory conditions including asthma, especially in resource-poor settings. Children with chronic asthma need to be treated as per internationally published guidelines with innovative models of disease monitoring and ongoing care during the pandemic. During the pandemic, children with acute asthma need to be managed carefully based on local guidelines and using strict infection control policies. The use of technology such as telehealth and various tools of asthma management including questionnaires and digital monitoring will play an important role in asthma management during the pandemic. Medical professionals, healthcare administrators, and governments should be sensitive to the evolving needs of the community and work closely to continue to provide services in a challenging yet unresolved pandemic.en_US
dc.identifier.affiliationsDepartment of Pediatrics, Boston Children’s Hospital, Harvard Medical School, Boston, MA 02115, USAen_US
dc.identifier.affiliationsSchool of Medicine, Apollo Institute of Medical Sciences and Research, Hyderabad, Indiaen_US
dc.identifier.affiliationsSchool of Medicine, University of Auckland, Auckland, New Zealanden_US
dc.identifier.affiliationsDepartment of Pediatrics, All India Institute of Medical Sciences, New Delhi, Indiaen_US
dc.identifier.affiliationsDepartment of Pediatric Respiratory Medicine, Starship Children’s Hospital, Auckland, New Zealanden_US
dc.identifier.citationKlouda Timothy, Pillarisetti Advait, Xie Annay, Kabra Sushil, Saradhi Naveen, Katwa Umakanth. Asthma Management in the Era of the COVID-19 Pandemic. Indian Journal of Pediatrics. 2022 Feb; 89(2): 163–168en_US
dc.identifier.issn0973-7693
dc.identifier.issn0019-5456
dc.identifier.placeIndiaen_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/223754
dc.languageenen_US
dc.publisherDr. K C Chaudhuri Foundationen_US
dc.relation.issuenumber2en_US
dc.relation.volume89en_US
dc.source.urihttps://doi.org/10.1007/s12098-021-03979-zen_US
dc.subjectAsthmaen_US
dc.subjectChildrenen_US
dc.subjectCOVID-19en_US
dc.subjectPandemicen_US
dc.subjectSocioeconomicen_US
dc.subjectTelehealthen_US
dc.titleAsthma Management in the Era of the COVID-19 Pandemicen_US
dc.typeJournal Articleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
IJP2022v89n2p163.pdf
Size:
524.31 KB
Format:
Adobe Portable Document Format
Download
Collections
Indian Journal of Pediatrics